Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation

Authors: Steven M Brunelli, Steven Wilson, Mahesh Krishnan, Allen R Nissenson

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Patient outcomes have been compared on the basis of the profit status of the dialysis provider (for-profit [FP] and not-for-profit [NFP]). In its annual report, United States Renal Data System (USRDS) provides dialysis provider level death and hospitalization rates adjusted by age, race, sex, and dialysis vintage; however, recent analyses have suggested that other variables impact these outcomes. Our current analysis of hospitalization and mortality rates of hemodialysis patients included adjustments for those used by the USRDS plus other potential confounders: facility geography (end-stage renal disease network), length of facility ownership, vascular access at first dialysis session, and pre-dialysis nephrology care.

Methods

We performed a provider level, retrospective analysis of 2010 hospitalization and mortality rates among US hemodialysis patients exclusively using USRDS sources. Crude and adjusted incidence rate ratios (IRRs) were calculated using the 4 standard USRDS patient factors plus the 4 potential confounders noted above.

Results

The analysis included 366,011 and 34,029 patients treated at FP and NFP facilities, respectively. There were statistical differences between the cohorts in geography, facility length of ownership, vascular access, and pre-dialysis nephrology care (p < 0.001), as well as age (p < 0.01), race (p < 0.001), and vintage (p < 0.001), but not sex (p = 0.12). When using standard USRDS adjustments, hospitalization and mortality rates for FP and NFP facilities were most disparate, favoring the NFP facilities. Rates were most similar between providers when adjustments were made for each of the 8 factors. With the FP IRR as the referent (1.0), the hospitalization IRR for NFP facilities was 1.00 (95% confidence interval [CI] 0.97-1.02; p = 0.69), while the NFP mortality IRR was 1.01 (95% CI 0.97-1.05; p = 0.64).

Conclusions

These data suggest there is no difference in mortality and hospitalization rates between FP and NFP dialysis clinics when appropriate statistical adjustments are made.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lee DK, Chertow GM, Zenios SA: Reexploring differences among for-profit and nonprofit dialysis providers. Health Serv Res. 2010, 45 (3): 633-646. 10.1111/j.1475-6773.2010.01103.x.CrossRefPubMedPubMedCentral Lee DK, Chertow GM, Zenios SA: Reexploring differences among for-profit and nonprofit dialysis providers. Health Serv Res. 2010, 45 (3): 633-646. 10.1111/j.1475-6773.2010.01103.x.CrossRefPubMedPubMedCentral
2.
go back to reference Zhang Y, Cotter DJ, Thamer M: The effect of dialysis chains on mortality among patients receiving hemodialysis. Health Serv Res. 2011, 46 (3): 747-767. 10.1111/j.1475-6773.2010.01219.x.CrossRefPubMedPubMedCentral Zhang Y, Cotter DJ, Thamer M: The effect of dialysis chains on mortality among patients receiving hemodialysis. Health Serv Res. 2011, 46 (3): 747-767. 10.1111/j.1475-6773.2010.01219.x.CrossRefPubMedPubMedCentral
3.
go back to reference Devereaux PJ, Schunemann HJ, Ravindran N, Bhandari M, Garg AX, Choi PT, Grant BJ, Haines T, Lacchetti C, Weaver B, Lavis JN, Cook DJ, Haslam DR, Sullivan T, Guyatt GH: Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA. 2002, 288 (19): 2449-2457. 10.1001/jama.288.19.2449.CrossRefPubMed Devereaux PJ, Schunemann HJ, Ravindran N, Bhandari M, Garg AX, Choi PT, Grant BJ, Haines T, Lacchetti C, Weaver B, Lavis JN, Cook DJ, Haslam DR, Sullivan T, Guyatt GH: Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA. 2002, 288 (19): 2449-2457. 10.1001/jama.288.19.2449.CrossRefPubMed
4.
go back to reference Foley RN, Fan Q, Liu J, Gilbertson DT, Weinhandl ED, Chen SC, Collins AJ: Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis. BMC Nephrol. 2008, 9: 6-10.1186/1471-2369-9-6.CrossRefPubMedPubMedCentral Foley RN, Fan Q, Liu J, Gilbertson DT, Weinhandl ED, Chen SC, Collins AJ: Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis. BMC Nephrol. 2008, 9: 6-10.1186/1471-2369-9-6.CrossRefPubMedPubMedCentral
5.
go back to reference Garg PP, Frick KD, Diener-West M, Powe NR: Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med. 1999, 341 (22): 1653-1660. 10.1056/NEJM199911253412205.CrossRefPubMed Garg PP, Frick KD, Diener-West M, Powe NR: Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med. 1999, 341 (22): 1653-1660. 10.1056/NEJM199911253412205.CrossRefPubMed
6.
go back to reference USRDS: United States Renal Data System 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2012, Bethesda, MD: United States Renal Data System USRDS: United States Renal Data System 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2012, Bethesda, MD: United States Renal Data System
7.
go back to reference Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol. 2007, 2 (1): 89-99.CrossRefPubMed Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol. 2007, 2 (1): 89-99.CrossRefPubMed
8.
go back to reference Hommel K, Madsen M, Kamper AL: The importance of early referral for the treatment of chronic kidney disease: a Danish nationwide cohort study. BMC Nephrol. 2012, 13: 108-10.1186/1471-2369-13-108.CrossRefPubMedPubMedCentral Hommel K, Madsen M, Kamper AL: The importance of early referral for the treatment of chronic kidney disease: a Danish nationwide cohort study. BMC Nephrol. 2012, 13: 108-10.1186/1471-2369-13-108.CrossRefPubMedPubMedCentral
9.
go back to reference Mendelssohn DC, Curtis B, Yeates K, Langlois S, MacRae JM, Semeniuk LM, Camacho F, McFarlane P: Suboptimal initiation of dialysis with and without early referral to a nephrologist. Nephrol Dial Transplant. 2011, 26 (9): 2959-2965. 10.1093/ndt/gfq843.CrossRefPubMed Mendelssohn DC, Curtis B, Yeates K, Langlois S, MacRae JM, Semeniuk LM, Camacho F, McFarlane P: Suboptimal initiation of dialysis with and without early referral to a nephrologist. Nephrol Dial Transplant. 2011, 26 (9): 2959-2965. 10.1093/ndt/gfq843.CrossRefPubMed
10.
go back to reference Hakim RM: Reducing early mortality in hemodialysis patients. Curr Opin Nephrol Hypertens. 2008, 17 (6): 595-599. 10.1097/MNH.0b013e3283136746.CrossRefPubMed Hakim RM: Reducing early mortality in hemodialysis patients. Curr Opin Nephrol Hypertens. 2008, 17 (6): 595-599. 10.1097/MNH.0b013e3283136746.CrossRefPubMed
11.
go back to reference Lynch JR, Wasse H, Armistead NC, McClellan WM: Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients. Am J Kidney Dis. 2011, 57 (1): 78-89. 10.1053/j.ajkd.2010.08.028.CrossRefPubMed Lynch JR, Wasse H, Armistead NC, McClellan WM: Achieving the goal of the Fistula First breakthrough initiative for prevalent maintenance hemodialysis patients. Am J Kidney Dis. 2011, 57 (1): 78-89. 10.1053/j.ajkd.2010.08.028.CrossRefPubMed
12.
go back to reference Van Wyck D, Robertson J, Nissenson A, Provenzano R, Kogod D: Relationship among length of facility ownership, clinical performance, and mortality. Clin J Am Soc Nephrol. 2010, 5 (2): 248-251. 10.2215/CJN.03700609.CrossRefPubMedPubMedCentral Van Wyck D, Robertson J, Nissenson A, Provenzano R, Kogod D: Relationship among length of facility ownership, clinical performance, and mortality. Clin J Am Soc Nephrol. 2010, 5 (2): 248-251. 10.2215/CJN.03700609.CrossRefPubMedPubMedCentral
13.
go back to reference Szczech LA, Klassen PS, Chua B, Hedayati SS, Flanigan M, McClellan WM, Reddan DN, Rettig RA, Frankenfield DL, Owen WF: Associations between CMS's clinical performance measures project benchmarks, profit structure, and mortality in dialysis units. Kidney Int. 2006, 69 (11): 2094-2100. 10.1038/sj.ki.5000267.CrossRefPubMed Szczech LA, Klassen PS, Chua B, Hedayati SS, Flanigan M, McClellan WM, Reddan DN, Rettig RA, Frankenfield DL, Owen WF: Associations between CMS's clinical performance measures project benchmarks, profit structure, and mortality in dialysis units. Kidney Int. 2006, 69 (11): 2094-2100. 10.1038/sj.ki.5000267.CrossRefPubMed
14.
go back to reference Gessert CE, Haller IV, Johnson BP: Regional variation in care at the end of life: discontinuation of dialysis. BMC Geriatr. 2013, 13: 39-10.1186/1471-2318-13-39.CrossRefPubMedPubMedCentral Gessert CE, Haller IV, Johnson BP: Regional variation in care at the end of life: discontinuation of dialysis. BMC Geriatr. 2013, 13: 39-10.1186/1471-2318-13-39.CrossRefPubMedPubMedCentral
15.
go back to reference Brooks JM, Irwin CP, Hunsicker LG, Flanigan MJ, Chrischilles EA, Pendergast JF: Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches. Health Serv Res. 2006, 41 (6): 2267-2289. 10.1111/j.1475-6773.2006.00581.x.CrossRefPubMedPubMedCentral Brooks JM, Irwin CP, Hunsicker LG, Flanigan MJ, Chrischilles EA, Pendergast JF: Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches. Health Serv Res. 2006, 41 (6): 2267-2289. 10.1111/j.1475-6773.2006.00581.x.CrossRefPubMedPubMedCentral
16.
go back to reference Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol. 2005, 16 (5): 1449-1455. 10.1681/ASN.2004090748.CrossRefPubMed Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol. 2005, 16 (5): 1449-1455. 10.1681/ASN.2004090748.CrossRefPubMed
17.
go back to reference McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV: Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol. 2009, 20 (5): 1078-1085. 10.1681/ASN.2008060624.CrossRefPubMedPubMedCentral McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV: Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol. 2009, 20 (5): 1078-1085. 10.1681/ASN.2008060624.CrossRefPubMedPubMedCentral
18.
go back to reference Hopson S, Frankenfield D, Rocco M, McClellan W: Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD clinical performance measures project. Am J Kidney Dis. 2008, 52 (4): 753-760. 10.1053/j.ajkd.2008.04.007.CrossRefPubMed Hopson S, Frankenfield D, Rocco M, McClellan W: Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD clinical performance measures project. Am J Kidney Dis. 2008, 52 (4): 753-760. 10.1053/j.ajkd.2008.04.007.CrossRefPubMed
19.
go back to reference Yan G, Cheung AK, Ma JZ, Yu AJ, Greene T, Oliver MN, Yu W, Norris KC: The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol. 2013, 8 (4): 610-618. 10.2215/CJN.07780812.CrossRefPubMedPubMedCentral Yan G, Cheung AK, Ma JZ, Yu AJ, Greene T, Oliver MN, Yu W, Norris KC: The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol. 2013, 8 (4): 610-618. 10.2215/CJN.07780812.CrossRefPubMedPubMedCentral
20.
go back to reference Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002, 162 (17): 2002-2006. 10.1001/archinte.162.17.2002.CrossRefPubMed Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002, 162 (17): 2002-2006. 10.1001/archinte.162.17.2002.CrossRefPubMed
21.
go back to reference Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, Collins AJ: Does predialysis nephrology care influence patient survival after initiation of dialysis?. Kidney Int. 2005, 67 (3): 1038-1046. 10.1111/j.1523-1755.2005.00168.x.CrossRefPubMed Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, Collins AJ: Does predialysis nephrology care influence patient survival after initiation of dialysis?. Kidney Int. 2005, 67 (3): 1038-1046. 10.1111/j.1523-1755.2005.00168.x.CrossRefPubMed
22.
go back to reference Winkelmayer WC, Owen WF, Levin R, Avorn J: A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003, 14 (2): 486-492. 10.1097/01.ASN.0000046047.66958.C3.CrossRefPubMed Winkelmayer WC, Owen WF, Levin R, Avorn J: A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003, 14 (2): 486-492. 10.1097/01.ASN.0000046047.66958.C3.CrossRefPubMed
23.
go back to reference Centers for Medicare and Medicaid Services: Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule. Fed Regist. 2012, 77 (218): 67450-67531. Centers for Medicare and Medicaid Services: Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule. Fed Regist. 2012, 77 (218): 67450-67531.
24.
go back to reference Wilson SM, Mayne TJ, Krishnan M, Holland J, Volz A, Good LS, Nissenson AR: CathAway fistula vascular access program achieves improved outcomes and sets a new standard of treatment for end-stage renal disease. Hemodial Int. 2013, 17 (1): 86-93. 10.1111/j.1542-4758.2012.00721.x.CrossRefPubMed Wilson SM, Mayne TJ, Krishnan M, Holland J, Volz A, Good LS, Nissenson AR: CathAway fistula vascular access program achieves improved outcomes and sets a new standard of treatment for end-stage renal disease. Hemodial Int. 2013, 17 (1): 86-93. 10.1111/j.1542-4758.2012.00721.x.CrossRefPubMed
25.
go back to reference Wilson SM, Robertson JA, Chen G, Goel P, Benner DA, Krishnan M, Mayne TJ, Nissenson AR: The IMPACT (incident management of patients, actions centered on treatment) program: a quality improvement approach for caring for patients initiating long-term hemodialysis. Am J Kidney Dis. 2012, 60 (3): 435-443. 10.1053/j.ajkd.2012.04.009.CrossRefPubMed Wilson SM, Robertson JA, Chen G, Goel P, Benner DA, Krishnan M, Mayne TJ, Nissenson AR: The IMPACT (incident management of patients, actions centered on treatment) program: a quality improvement approach for caring for patients initiating long-term hemodialysis. Am J Kidney Dis. 2012, 60 (3): 435-443. 10.1053/j.ajkd.2012.04.009.CrossRefPubMed
26.
go back to reference Wingard RL, Pupim LB, Krishnan M, Shintani A, Ikizler TA, Hakim RM: Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program. Clin J Am Soc Nephrol. 2007, 2 (6): 1170-1175. 10.2215/CJN.04261206.CrossRefPubMed Wingard RL, Pupim LB, Krishnan M, Shintani A, Ikizler TA, Hakim RM: Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program. Clin J Am Soc Nephrol. 2007, 2 (6): 1170-1175. 10.2215/CJN.04261206.CrossRefPubMed
27.
go back to reference Weinhandl ED, Arneson TJ, St Peter WL: Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report. Am J Kidney Dis. 2013, 62 (3): 557-567. 10.1053/j.ajkd.2013.02.360.CrossRefPubMed Weinhandl ED, Arneson TJ, St Peter WL: Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report. Am J Kidney Dis. 2013, 62 (3): 557-567. 10.1053/j.ajkd.2013.02.360.CrossRefPubMed
Metadata
Title
Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation
Authors
Steven M Brunelli
Steven Wilson
Mahesh Krishnan
Allen R Nissenson
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-121

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.